Astha Lamichhane

ORCID: 0000-0003-1968-7298

Also affiliated with Texas A&M University

MedicineBiochemistry, Genetics and Molecular BiologyEngineering

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

0in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 5 papers. Top paper: “Inhibiting BRAF/EGFR/MEK suppresses cancer stemness and drug resistance of primary colorectal cancer cells”.

Inhibiting BRAF/EGFR/MEK suppresses cancer stemness and drug resistance of primary colorectal cancer cells

Oncotarget(2023)10.18632/oncotarget.28517

N/A

0DataRank · unranked

7 citations

Gary D. Luker, Seema Agarwal, Hossein Tavana, Astha Lamichhane

Three-Dimensional Tumor Models to Study Cancer Stemness-Mediated Drug Resistance

Cellular and Molecular Bioengineering(2024)10.1007/s12195-024-00798-y

N/A

0DataRank · unranked

12 citations

Hossein Tavana, Astha Lamichhane

A gravity-driven tissue chip to study the efficacy and toxicity of cancer therapeutics

Lab on a Chip(2024)10.1039/d4lc00404c

N/A

0DataRank · unranked

2 citations

Astha Lamichhane, Prasiddha Guragain, Gary D. Luker, Hossein Tavana, Pouria Rafsanjani Nejad

Extracellular Fibronectin and Hyaluronic Acid Effects on Tumorigenic Functions of Triple‐Negative Breast Cancer Cells

Journal of Biomedical Materials Research Part A(2025)10.1002/jbm.a.37906

N/A

0DataRank · unranked

3 citations

Nina Treacher, Astha Lamichhane, Anju Rana Magar, Hossein Tavana, Jacob Heiss

Targeting CAFs-Mediated Stromal Signaling in a Patient-Derived Organotypic Colorectal Tumor Model

Molecular Cancer Therapeutics(2025)10.1158/1535-7163.mct-24-0756

N/A

0DataRank · unranked

2 citations

Prasiddha Guragain, Jacob Heiss, Pouria Rafsanjani Nejad, Anju Rana Magar, Nicholas Ciavattone +4 more